Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1374339 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $14.92Day +6.12%Mkt cap $126M1Y −29.0%Off 52W high −45.5%Vol (1Y) 100.1%
Daily closing price, split-adjusted to the current basis; 3y shown of 985 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest2.6% of sh out |
| Days to cover3.1d |
| 13F net flow (QoQ)+5.33% |
| Top-10 13F concentration90.2% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$40.6M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+118.4% |
| 1Y−29.0% |
| 3Y−79.2% |
| Since incept. (ann.)−43.8% |
Total return through 2026-07-30 · series begins 2022-08-18. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)100.1% |
| Ann. volatility (3Y)136.1% |
| Sharpe (1Y)0.14 |
| Sharpe (3Y)0.15 |
| Max drawdown (1Y)−67.8% |
| Max drawdown (3Y)−91.3% |
| Beta (3Y vs SPY)−0.76 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 1.3M | $16M | 14.42% | new |
| Deep Track Capital, LP | 835,655 | $11M | 9.32% | new |
| WELLINGTON MANAGEMENT GROUP LLP | 696,378 | $9M | 7.77% | new |
| Trails Edge Capital Partners, LP | 557,103 | $7M | 6.21% | new |
| Ally Bridge Group (NY) LLC | 414,219 | $5M | 4.62% | +66.1% |
| Woodline Partners LP | 395,295 | $5M | 4.41% | new |
| GREAT POINT PARTNERS LLC | 371,402 | $5M | 4.14% | new |
| Yu Fan | 329,760 | $4M | 3.68% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-12 | −$1.26 | — | — | — |
| 2025-09-30 | 2025-11-12 | — | — | — | — |
| 2025-06-30 | 2025-08-13 | — | — | — | — |
| 2025-03-31 | 2025-05-12 | — | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
